Scandinavian ChemoTech AB (publ) announced that after more than a year of collaboration, the company and the IR consultant, Jonathan Furelid, have mutually decided to end the collaboration as a result of changing needs for the company regarding its communication. Jonathan thus leaves the management team as of December 31.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 SEK | -1.32% | 0.00% | -17.04% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.04% | 3.66M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- CMOTEC B Stock
- News Scandinavian ChemoTech AB
- Scandinavian Chemotech Thanks for the Cooperation with Its IR Consultant Who Leaves the Management Team